Form 4: Lemaitre Vascular Director Bridget A. Ross Reports Dividend Equivalent Rights Acquisition

Director Bridget A. Ross reported the acquisition of dividend equivalent rights related to restricted stock unit and performance share unit awards.

Summary

• On May 30, 2024, Bridget A. Ross, a director of Lemaitre Vascular Inc. (LMAT), reported the acquisition of dividend equivalent rights.
• These rights are associated with previously granted restricted stock unit (RSU) and performance share unit (PSU) awards.
• The dividend equivalent rights vest proportionately with the underlying awards and are economically equivalent to shares of Lemaitre Vascular's common stock.
• The acquired dividend equivalent rights are related to awards granted on December 11, 2021, December 12, 2022 (both RSU and PSU), and December 8, 2023.
• The total dividend equivalent rights acquired are 0.402, 0.8146, 0.8146, and 1.0426, corresponding to the respective grant dates.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing detailing the acquisition of dividend equivalent rights, which is a neutral event. The sentiment is slightly positive as it reflects ongoing equity compensation.

Industry Context

This filing is a routine disclosure related to director compensation and equity awards, common in publicly traded companies. It reflects ongoing alignment of director interests with shareholder value through equity-based compensation.

Stakeholder Impact

• The acquisition of dividend equivalent rights has a minor positive impact on director alignment with shareholder interests.

Key Dates